tiprankstipranks
Black Bird Biotech (BBBT)
OTHER OTC:BBBT
US Market

Black Bird Biotech (BBBT) Financial Statements

25 Followers

Black Bird Biotech Financial Overview

Black Bird Biotech's market cap is currently ―. The company's EPS TTM is $-0.001; its P/E ratio is -5.56; Black Bird Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 3.94K$ 6.99K$ 7.38K$ 12.08K$ 25.74K
Gross Profit$ 1.42K$ 6.99K$ 3.39K$ 1.51K$ 13.38K
EBIT$ -10.76K$ -94.37K$ -82.77K$ -126.35K$ -178.26K
EBITDA$ 41.70K-$ -81.66K$ -40.78K$ -156.03K
Net Income Common Stockholders$ -131.22K$ -196.96K$ -266.93K$ -241.02K$ -224.79K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 6.72K$ 7.23K$ 0.00$ 66.18K
Total Assets$ 98.78K$ 106.35K$ 191.16K$ 218.51K$ 168.51K
Total Debt$ 748.11K$ 729.49K$ 718.65K$ 0.00$ 655.08K
Net Debt$ 748.11K$ 722.77K$ 711.42K$ 0.00$ 588.91K
Total Liabilities$ 1.02M$ 977.64K$ 917.17K$ 868.68K$ 826.17K
Stockholders Equity$ -922.78K$ -871.29K$ -726.00K$ -650.17K$ -657.66K
Cash Flow-
Free Cash Flow$ -4.90K-$ -99.04K$ -114.24K$ -124.60K
Operating Cash Flow$ -4.90K-$ -99.04K$ -114.24K$ -124.60K
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 3.91K-$ 61.82K$ 92.52K$ 138.55K
Currency in USD

Black Bird Biotech Earnings and Revenue History

Black Bird Biotech Debt to Assets

Black Bird Biotech Cash Flow

Black Bird Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis